Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Acquisition

4 May 2022 07:00

RNS Number : 1863K
Restore PLC
04 May 2022
 

4 May 2022

 

Restore plc

("Restore" or the "Group" or "Company")

 

Strategic acquisition increases Restore Technology capability

 

 

Restore (AIM: RST), the UK's leading provider of digital and information management and secure lifecycle services, is pleased to announce that it acquired 100% of the share capital of Ultratec (Holdings) Limited ("Ultratec") on 3rd May 2022.

 

This investment represents a further milestone in the Group's strategic development of Restore Technology.

 

Ultratec is a highly regarded provider of secure data erasure and physical data destruction services, bespoke technology recycling solutions, hard drive parts supply and Data Centre focussed hardware maintenance services.

 

A key feature of the business are the innovative and proprietary software solutions, Genesis* and Nemesis*. Both these products deliver additional value by extending the life of hard drive technologies, improving re-use recovery rates and securely erasing data substantially faster than comparable software solutions. The business has around 70 staff based in two locations at Stevenage and Henlow.

 

For the year to 31st March 2022, Ultratec achieved a revenue of £7.6 million, generating a profit before tax of £1.2 million and had net assets of £1.8 million. The business is being acquired in cash for an enterprise value of £9.4 million. In addition to the additional technical capability provided by the Genesis and Nemesis technologies, the combination will further increase the scale of Restore Technology and achieve synergies across revenues and operations.

 

*Genesis was developed by Ultratec as a proprietary software and hardware appliance that securely erases data on various hard disk formats and will also reconstruct hard drives to make previously damaged hard drives useable again. The appliance includes cloud based software to ease deployment and is delivered with a subscription model with recuring revenues. Nemesis performs the same functionality as Genesis but with networking equipment which is a growing market with the increasing amounts of data on networking devices posing a security risk for organisations.

 

www.ultratec.co.uk/genesis

www.ultratestsolutions.com

 

CHARLES BLIGH, CEO, COMMENTED:

 

"I am delighted to welcome the team at Ultratec to the Group and we look forward to developing the business together as part of Restore Technology, our rapidly growing IT lifecycle services business.

 

The team at Ultratec have an excellent reputation in the sector with a specialist focus on hard drive and storage products from repair, erasure and resale. Their innovative Genesis and Nemesis technologies represent opportunities to further expand our capabilities in technology lifecycle services. I am excited about this acquisition and the opportunity it represents for our business."

 

 

For further information:

Restore plc

www.restoreplc.com

Charles Bligh, CEONeil Ritchie, CFO

+44 (0) 207 409 2420

Investec (Nominated Adviser and Joint Broker)

www.investec.com

Carlton Nelson

James Rudd

 

+44 (0) 207 597 5970

Canaccord Genuity (Joint Broker, Corporate Advisor))

www.canaccordgenuity.com

Max Hartley

Chris Robinson

 

+44 (0) 207 523 8000

Citi (Joint Broker)

www.citigroup.com

Stuart Field

Luke Spells

 

+44 (0) 207 986 4074

Buchanan Communications (PR enquiries)

www.buchanan.uk.com

Charles Ryland

Stephanie Whitmore

 

+44 (0) 207 466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSSAFMDEESEDI
Date   Source Headline
1st Jun 202610:55 amRNSTransaction in Own Shares
26th May 20261:49 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSDirector/PDMR Shareholding
18th May 202610:27 amRNSTransaction in Own Shares
13th May 202612:45 pmRNSResult of Annual General Meeting
12th May 20267:00 amRNSTrading update
11th May 202611:10 amRNSTransaction in Own Shares
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20269:31 amRNSHolding(s) in Company
5th May 20261:05 pmRNSTransaction in Own Shares
27th Apr 202610:45 amRNSTransaction in Own Shares
23rd Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20269:58 amRNSTransaction in Own Shares
13th Apr 20269:43 amRNSTransaction in Own Shares
9th Apr 20261:58 pmRNSBoard Change
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 202611:46 amRNSHolding(s) in Company
7th Apr 202610:02 amRNSTransaction in Own Shares
30th Mar 202611:12 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
12th Mar 20267:00 amRNSFull Year 2025 Results
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
9th Mar 20269:23 amRNSHolding(s) in Company
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
10th Dec 202511:33 amRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSHolding(s) in Company
9th Dec 20257:01 amRNSDisposal of Restore Harrow Green
9th Dec 20257:00 amRNSTrading update
23rd Oct 20254:00 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSAnalyst and investor site visit
29th Jul 20257:00 amRNSHalf year 2025 results
14th Jul 202511:39 amRNS-RNotice of Presentation with Equity Development
7th Jul 202511:10 amRNSHolding(s) in Company
16th Jun 20252:28 pmRNSHoldings in Company
14th May 20251:12 pmRNSGrant of SAYE Options and PDMR Dealings
13th May 20253:10 pmRNSResult of AGM
13th May 20257:00 amRNSTrading update
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
28th Mar 20252:02 pmRNSHolding(s) in Company
20th Mar 20253:59 pmRNSHolding(s) in Company
17th Mar 20253:56 pmRNSHolding(s) in Company
17th Mar 20251:48 pmRNSDirector/PDMR Shareholding
14th Mar 20258:37 amRNSDirector/PDMR Shareholding
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.